Prevent Bleeding in Major Surgery

1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Octapharma
OctapharmaAustria - Vienna
1 program
1
human VWF/FVIII concentratePhase 31 trial
Active Trials
NCT01365546Completed30Est. Apr 2014

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Octapharmahuman VWF/FVIII concentrate

Clinical Trials (1)

Total enrollment: 30 patients across 1 trials

NCT01365546Octapharmahuman VWF/FVIII concentrate

Wilate in Subjects With Von Willebrand Disease Who Undergo Surgery

Start: Jun 2011Est. completion: Apr 201430 patients
Phase 3Completed

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 late-stage (Phase 3) programs — potential near-term approvals
1 companies competing in this space